Evaluating the role of CD4-lymphocyte counts as surrogate endpoints in human immunodeficiency virus clinical trials.
Nagelkerke
N J
NJ
Mwatha
A
A
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy; D018791:CD4 Lymphocyte Count; D002986:Clinical Trials as Topic / Q000379:methods; D003627:Data Interpretation, Statistical; D015658:HIV Infections / Q000276:immunology*; D006801:Humans; D011379:Prognosis; D015215:Zidovudine / Q000627:therapeutic use
D015215:Zidovudine